nodes	percent_of_prediction	percent_of_DWPC	metapath
Busulfan—GSTM1—Carboplatin—esophageal cancer	0.228	0.313	CbGbCtD
Busulfan—GSTM1—Cisplatin—esophageal cancer	0.195	0.267	CbGbCtD
Busulfan—GSTP1—Carboplatin—esophageal cancer	0.165	0.226	CbGbCtD
Busulfan—GSTP1—Cisplatin—esophageal cancer	0.141	0.193	CbGbCtD
Busulfan—MGST2—bronchus—esophageal cancer	0.00345	0.0762	CbGeAlD
Busulfan—GSTM1—neck—esophageal cancer	0.00324	0.0715	CbGeAlD
Busulfan—GSTP1—exocrine gland—esophageal cancer	0.00317	0.0701	CbGeAlD
Busulfan—GSTA1—epithelium—esophageal cancer	0.00298	0.0658	CbGeAlD
Busulfan—GSTA1—bronchus—esophageal cancer	0.00293	0.0648	CbGeAlD
Busulfan—GSTA1—digestive system—esophageal cancer	0.00227	0.0501	CbGeAlD
Busulfan—MGST2—lung—esophageal cancer	0.00223	0.0492	CbGeAlD
Busulfan—GSTA2—epithelium—esophageal cancer	0.00215	0.0475	CbGeAlD
Busulfan—GSTA2—bronchus—esophageal cancer	0.00212	0.0468	CbGeAlD
Busulfan—GSTP1—neck—esophageal cancer	0.00203	0.0448	CbGeAlD
Busulfan—GSTA1—lung—esophageal cancer	0.00189	0.0418	CbGeAlD
Busulfan—GSTM1—digestive system—esophageal cancer	0.00168	0.037	CbGeAlD
Busulfan—GSTA2—digestive system—esophageal cancer	0.00163	0.0361	CbGeAlD
Busulfan—MGST2—lymph node—esophageal cancer	0.00152	0.0336	CbGeAlD
Busulfan—GSTM1—lung—esophageal cancer	0.0014	0.0309	CbGeAlD
Busulfan—GSTP1—epithelium—esophageal cancer	0.00138	0.0305	CbGeAlD
Busulfan—GSTA2—lung—esophageal cancer	0.00137	0.0302	CbGeAlD
Busulfan—GSTP1—bronchus—esophageal cancer	0.00136	0.03	CbGeAlD
Busulfan—GSTP1—smooth muscle tissue—esophageal cancer	0.00133	0.0294	CbGeAlD
Busulfan—GSTP1—trachea—esophageal cancer	0.00122	0.027	CbGeAlD
Busulfan—GSTP1—digestive system—esophageal cancer	0.00105	0.0232	CbGeAlD
Busulfan—GSTM1—lymph node—esophageal cancer	0.000957	0.0212	CbGeAlD
Busulfan—GSTP1—lung—esophageal cancer	0.000877	0.0194	CbGeAlD
Busulfan—GSTP1—lymph node—esophageal cancer	0.0006	0.0133	CbGeAlD
Busulfan—CYP3A4—digestive system—esophageal cancer	0.000428	0.00946	CbGeAlD
Busulfan—Inflammation—Capecitabine—esophageal cancer	0.000375	0.00351	CcSEcCtD
Busulfan—Hiccups—Capecitabine—esophageal cancer	0.000363	0.00341	CcSEcCtD
Busulfan—Hyponatraemia—Cisplatin—esophageal cancer	0.000359	0.00337	CcSEcCtD
Busulfan—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.000358	0.00336	CcSEcCtD
Busulfan—Pleural effusion—Methotrexate—esophageal cancer	0.000353	0.00331	CcSEcCtD
Busulfan—Fungal infection—Methotrexate—esophageal cancer	0.00035	0.00329	CcSEcCtD
Busulfan—Skin exfoliation—Capecitabine—esophageal cancer	0.000347	0.00325	CcSEcCtD
Busulfan—Necrosis—Methotrexate—esophageal cancer	0.000345	0.00323	CcSEcCtD
Busulfan—Blood creatinine increased—Cisplatin—esophageal cancer	0.000335	0.00314	CcSEcCtD
Busulfan—Oesophagitis—Capecitabine—esophageal cancer	0.000332	0.00311	CcSEcCtD
Busulfan—Neoplasm—Capecitabine—esophageal cancer	0.000328	0.00308	CcSEcCtD
Busulfan—Hypokalaemia—Cisplatin—esophageal cancer	0.000326	0.00305	CcSEcCtD
Busulfan—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000322	0.00302	CcSEcCtD
Busulfan—Sepsis—Capecitabine—esophageal cancer	0.000315	0.00296	CcSEcCtD
Busulfan—Extravasation—Methotrexate—esophageal cancer	0.00031	0.00291	CcSEcCtD
Busulfan—Pancreatitis—Cisplatin—esophageal cancer	0.000303	0.00284	CcSEcCtD
Busulfan—Skin discolouration—Methotrexate—esophageal cancer	0.000299	0.00281	CcSEcCtD
Busulfan—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.000297	0.00279	CcSEcCtD
Busulfan—Pancytopenia—Cisplatin—esophageal cancer	0.000294	0.00276	CcSEcCtD
Busulfan—Glossitis—Methotrexate—esophageal cancer	0.000293	0.00275	CcSEcCtD
Busulfan—Oliguria—Methotrexate—esophageal cancer	0.000293	0.00275	CcSEcCtD
Busulfan—Hyperuricaemia—Methotrexate—esophageal cancer	0.000292	0.00274	CcSEcCtD
Busulfan—Hot flush—Capecitabine—esophageal cancer	0.000282	0.00265	CcSEcCtD
Busulfan—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000279	0.00262	CcSEcCtD
Busulfan—Menopausal symptoms—Capecitabine—esophageal cancer	0.000279	0.00262	CcSEcCtD
Busulfan—Inflammation—Methotrexate—esophageal cancer	0.000279	0.00262	CcSEcCtD
Busulfan—Atrial fibrillation—Capecitabine—esophageal cancer	0.000278	0.00261	CcSEcCtD
Busulfan—Renal impairment—Capecitabine—esophageal cancer	0.000277	0.0026	CcSEcCtD
Busulfan—Dermatitis bullous—Capecitabine—esophageal cancer	0.000276	0.00259	CcSEcCtD
Busulfan—Respiratory failure—Methotrexate—esophageal cancer	0.000275	0.00258	CcSEcCtD
Busulfan—Blood uric acid increased—Methotrexate—esophageal cancer	0.000275	0.00258	CcSEcCtD
Busulfan—Renal failure—Cisplatin—esophageal cancer	0.000271	0.00254	CcSEcCtD
Busulfan—Lethargy—Capecitabine—esophageal cancer	0.000269	0.00253	CcSEcCtD
Busulfan—Stomatitis—Cisplatin—esophageal cancer	0.000269	0.00252	CcSEcCtD
Busulfan—Hyponatraemia—Capecitabine—esophageal cancer	0.000265	0.00248	CcSEcCtD
Busulfan—Cystitis noninfective—Methotrexate—esophageal cancer	0.000264	0.00248	CcSEcCtD
Busulfan—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000264	0.00247	CcSEcCtD
Busulfan—Cystitis—Methotrexate—esophageal cancer	0.000261	0.00245	CcSEcCtD
Busulfan—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000261	0.00245	CcSEcCtD
Busulfan—Skin exfoliation—Methotrexate—esophageal cancer	0.000258	0.00242	CcSEcCtD
Busulfan—Aplastic anaemia—Methotrexate—esophageal cancer	0.000254	0.00238	CcSEcCtD
Busulfan—Bradycardia—Cisplatin—esophageal cancer	0.000252	0.00236	CcSEcCtD
Busulfan—Coma—Methotrexate—esophageal cancer	0.000247	0.00232	CcSEcCtD
Busulfan—Blood creatinine increased—Capecitabine—esophageal cancer	0.000247	0.00232	CcSEcCtD
Busulfan—Neoplasm—Methotrexate—esophageal cancer	0.000245	0.00229	CcSEcCtD
Busulfan—Bladder pain—Methotrexate—esophageal cancer	0.000245	0.00229	CcSEcCtD
Busulfan—Urinary tract disorder—Cisplatin—esophageal cancer	0.000244	0.00229	CcSEcCtD
Busulfan—Connective tissue disorder—Cisplatin—esophageal cancer	0.000243	0.00228	CcSEcCtD
Busulfan—Urethral disorder—Cisplatin—esophageal cancer	0.000243	0.00228	CcSEcCtD
Busulfan—Gynaecomastia—Methotrexate—esophageal cancer	0.000242	0.00227	CcSEcCtD
Busulfan—Pulmonary oedema—Methotrexate—esophageal cancer	0.000241	0.00226	CcSEcCtD
Busulfan—Hypokalaemia—Capecitabine—esophageal cancer	0.00024	0.00225	CcSEcCtD
Busulfan—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000237	0.00223	CcSEcCtD
Busulfan—Sepsis—Methotrexate—esophageal cancer	0.000235	0.0022	CcSEcCtD
Busulfan—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000233	0.00218	CcSEcCtD
Busulfan—Eye disorder—Cisplatin—esophageal cancer	0.000231	0.00217	CcSEcCtD
Busulfan—Flushing—Cisplatin—esophageal cancer	0.00023	0.00216	CcSEcCtD
Busulfan—Cardiac disorder—Cisplatin—esophageal cancer	0.00023	0.00216	CcSEcCtD
Busulfan—Abdominal distension—Capecitabine—esophageal cancer	0.000229	0.00215	CcSEcCtD
Busulfan—Asthma—Capecitabine—esophageal cancer	0.000228	0.00214	CcSEcCtD
Busulfan—Immune system disorder—Cisplatin—esophageal cancer	0.000224	0.0021	CcSEcCtD
Busulfan—Mediastinal disorder—Cisplatin—esophageal cancer	0.000223	0.00209	CcSEcCtD
Busulfan—Arrhythmia—Cisplatin—esophageal cancer	0.000221	0.00207	CcSEcCtD
Busulfan—Alopecia—Cisplatin—esophageal cancer	0.000219	0.00205	CcSEcCtD
Busulfan—Pancytopenia—Capecitabine—esophageal cancer	0.000216	0.00203	CcSEcCtD
Busulfan—Malnutrition—Cisplatin—esophageal cancer	0.000215	0.00202	CcSEcCtD
Busulfan—Erythema—Cisplatin—esophageal cancer	0.000215	0.00202	CcSEcCtD
Busulfan—Neutropenia—Capecitabine—esophageal cancer	0.000213	0.002	CcSEcCtD
Busulfan—Dysuria—Capecitabine—esophageal cancer	0.000213	0.002	CcSEcCtD
Busulfan—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000208	0.00195	CcSEcCtD
Busulfan—Weight increased—Capecitabine—esophageal cancer	0.000207	0.00195	CcSEcCtD
Busulfan—Weight decreased—Capecitabine—esophageal cancer	0.000206	0.00193	CcSEcCtD
Busulfan—Hyperglycaemia—Capecitabine—esophageal cancer	0.000206	0.00193	CcSEcCtD
Busulfan—Pneumonia—Capecitabine—esophageal cancer	0.000204	0.00192	CcSEcCtD
Busulfan—Infestation NOS—Capecitabine—esophageal cancer	0.000203	0.00191	CcSEcCtD
Busulfan—Infestation—Capecitabine—esophageal cancer	0.000203	0.00191	CcSEcCtD
Busulfan—Depression—Capecitabine—esophageal cancer	0.000203	0.0019	CcSEcCtD
Busulfan—Lethargy—Methotrexate—esophageal cancer	0.0002	0.00188	CcSEcCtD
Busulfan—Renal failure—Capecitabine—esophageal cancer	0.0002	0.00187	CcSEcCtD
Busulfan—Anaemia—Cisplatin—esophageal cancer	0.000199	0.00187	CcSEcCtD
Busulfan—Jaundice—Capecitabine—esophageal cancer	0.000198	0.00186	CcSEcCtD
Busulfan—Stomatitis—Capecitabine—esophageal cancer	0.000198	0.00186	CcSEcCtD
Busulfan—Haematuria—Capecitabine—esophageal cancer	0.000194	0.00182	CcSEcCtD
Busulfan—Leukopenia—Cisplatin—esophageal cancer	0.000193	0.00181	CcSEcCtD
Busulfan—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000192	0.0018	CcSEcCtD
Busulfan—Epistaxis—Capecitabine—esophageal cancer	0.000192	0.0018	CcSEcCtD
Busulfan—Agranulocytosis—Capecitabine—esophageal cancer	0.00019	0.00178	CcSEcCtD
Busulfan—Convulsion—Cisplatin—esophageal cancer	0.000187	0.00175	CcSEcCtD
Busulfan—Bradycardia—Capecitabine—esophageal cancer	0.000186	0.00174	CcSEcCtD
Busulfan—Myalgia—Cisplatin—esophageal cancer	0.000183	0.00172	CcSEcCtD
Busulfan—Haemoglobin—Capecitabine—esophageal cancer	0.000183	0.00172	CcSEcCtD
Busulfan—Rhinitis—Capecitabine—esophageal cancer	0.000183	0.00172	CcSEcCtD
Busulfan—Anxiety—Cisplatin—esophageal cancer	0.000183	0.00172	CcSEcCtD
Busulfan—Haemorrhage—Capecitabine—esophageal cancer	0.000182	0.00171	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000182	0.00171	CcSEcCtD
Busulfan—Pharyngitis—Capecitabine—esophageal cancer	0.000181	0.0017	CcSEcCtD
Busulfan—Urinary tract disorder—Capecitabine—esophageal cancer	0.00018	0.00169	CcSEcCtD
Busulfan—Connective tissue disorder—Capecitabine—esophageal cancer	0.000179	0.00168	CcSEcCtD
Busulfan—Urethral disorder—Capecitabine—esophageal cancer	0.000179	0.00168	CcSEcCtD
Busulfan—Oedema—Cisplatin—esophageal cancer	0.000176	0.00165	CcSEcCtD
Busulfan—Infection—Cisplatin—esophageal cancer	0.000175	0.00164	CcSEcCtD
Busulfan—GSTA1—Metabolism—BLVRB—esophageal cancer	0.000173	0.00144	CbGpPWpGaD
Busulfan—MGST2—Metabolism—CA1—esophageal cancer	0.000173	0.00144	CbGpPWpGaD
Busulfan—MGST2—Metabolism—SLC10A2—esophageal cancer	0.000173	0.00144	CbGpPWpGaD
Busulfan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.000173	0.00144	CbGpPWpGaD
Busulfan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.000173	0.00144	CbGpPWpGaD
Busulfan—Erythema multiforme—Capecitabine—esophageal cancer	0.000172	0.00162	CcSEcCtD
Busulfan—Nervous system disorder—Cisplatin—esophageal cancer	0.000172	0.00162	CcSEcCtD
Busulfan—Thrombocytopenia—Cisplatin—esophageal cancer	0.000172	0.00162	CcSEcCtD
Busulfan—Tachycardia—Cisplatin—esophageal cancer	0.000172	0.00161	CcSEcCtD
Busulfan—Skin disorder—Cisplatin—esophageal cancer	0.000171	0.0016	CcSEcCtD
Busulfan—Eye disorder—Capecitabine—esophageal cancer	0.00017	0.0016	CcSEcCtD
Busulfan—Asthma—Methotrexate—esophageal cancer	0.00017	0.00159	CcSEcCtD
Busulfan—Flushing—Capecitabine—esophageal cancer	0.000169	0.00159	CcSEcCtD
Busulfan—Cardiac disorder—Capecitabine—esophageal cancer	0.000169	0.00159	CcSEcCtD
Busulfan—Anorexia—Cisplatin—esophageal cancer	0.000168	0.00157	CcSEcCtD
Busulfan—Pancreatitis—Methotrexate—esophageal cancer	0.000166	0.00156	CcSEcCtD
Busulfan—Angiopathy—Capecitabine—esophageal cancer	0.000166	0.00155	CcSEcCtD
Busulfan—CYP3A4—Estrogen metabolism—CYP1B1—esophageal cancer	0.000165	0.00138	CbGpPWpGaD
Busulfan—Immune system disorder—Capecitabine—esophageal cancer	0.000165	0.00155	CcSEcCtD
Busulfan—Mediastinal disorder—Capecitabine—esophageal cancer	0.000164	0.00154	CcSEcCtD
Busulfan—Hypotension—Cisplatin—esophageal cancer	0.000164	0.00154	CcSEcCtD
Busulfan—Chills—Capecitabine—esophageal cancer	0.000164	0.00154	CcSEcCtD
Busulfan—Arrhythmia—Capecitabine—esophageal cancer	0.000163	0.00153	CcSEcCtD
Busulfan—GSTM1—C-MYB transcription factor network—CCND1—esophageal cancer	0.000163	0.00135	CbGpPWpGaD
Busulfan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.000162	0.00135	CbGpPWpGaD
Busulfan—Alopecia—Capecitabine—esophageal cancer	0.000161	0.00151	CcSEcCtD
Busulfan—Pancytopenia—Methotrexate—esophageal cancer	0.000161	0.00151	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00016	0.0015	CcSEcCtD
Busulfan—Mental disorder—Capecitabine—esophageal cancer	0.00016	0.0015	CcSEcCtD
Busulfan—Malnutrition—Capecitabine—esophageal cancer	0.000159	0.00149	CcSEcCtD
Busulfan—Erythema—Capecitabine—esophageal cancer	0.000159	0.00149	CcSEcCtD
Busulfan—Dysuria—Methotrexate—esophageal cancer	0.000159	0.00149	CcSEcCtD
Busulfan—Neutropenia—Methotrexate—esophageal cancer	0.000159	0.00149	CcSEcCtD
Busulfan—MGST2—Metabolism—CA2—esophageal cancer	0.000158	0.00132	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—CDKN1A—esophageal cancer	0.000158	0.00131	CbGpPWpGaD
Busulfan—Dyspnoea—Cisplatin—esophageal cancer	0.000157	0.00147	CcSEcCtD
Busulfan—Erectile dysfunction—Methotrexate—esophageal cancer	0.000156	0.00147	CcSEcCtD
Busulfan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.000154	0.00128	CbGpPWpGaD
Busulfan—Back pain—Capecitabine—esophageal cancer	0.000154	0.00144	CcSEcCtD
Busulfan—Decreased appetite—Cisplatin—esophageal cancer	0.000153	0.00143	CcSEcCtD
Busulfan—Pneumonia—Methotrexate—esophageal cancer	0.000152	0.00143	CcSEcCtD
Busulfan—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000152	0.00142	CcSEcCtD
Busulfan—Infestation—Methotrexate—esophageal cancer	0.000151	0.00142	CcSEcCtD
Busulfan—Infestation NOS—Methotrexate—esophageal cancer	0.000151	0.00142	CcSEcCtD
Busulfan—Depression—Methotrexate—esophageal cancer	0.000151	0.00142	CcSEcCtD
Busulfan—Pain—Cisplatin—esophageal cancer	0.00015	0.00141	CcSEcCtD
Busulfan—GSTM1—C-MYB transcription factor network—EP300—esophageal cancer	0.00015	0.00125	CbGpPWpGaD
Busulfan—Renal failure—Methotrexate—esophageal cancer	0.000149	0.0014	CcSEcCtD
Busulfan—Stomatitis—Methotrexate—esophageal cancer	0.000147	0.00138	CcSEcCtD
Busulfan—GSTA1—Metabolism—SLC10A2—esophageal cancer	0.000147	0.00123	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—CA1—esophageal cancer	0.000147	0.00123	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PLCE1—esophageal cancer	0.000147	0.00123	CbGpPWpGaD
Busulfan—MGST2—Metabolism—ADH7—esophageal cancer	0.000147	0.00123	CbGpPWpGaD
Busulfan—Anaemia—Capecitabine—esophageal cancer	0.000147	0.00138	CcSEcCtD
Busulfan—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.000146	0.00122	CbGpPWpGaD
Busulfan—Feeling abnormal—Cisplatin—esophageal cancer	0.000145	0.00136	CcSEcCtD
Busulfan—Haematuria—Methotrexate—esophageal cancer	0.000144	0.00135	CcSEcCtD
Busulfan—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000143	0.00134	CcSEcCtD
Busulfan—Epistaxis—Methotrexate—esophageal cancer	0.000143	0.00134	CcSEcCtD
Busulfan—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.000143	0.00119	CbGpPWpGaD
Busulfan—Leukopenia—Capecitabine—esophageal cancer	0.000142	0.00133	CcSEcCtD
Busulfan—Agranulocytosis—Methotrexate—esophageal cancer	0.000141	0.00132	CcSEcCtD
Busulfan—Body temperature increased—Cisplatin—esophageal cancer	0.000139	0.0013	CcSEcCtD
Busulfan—Cough—Capecitabine—esophageal cancer	0.000139	0.0013	CcSEcCtD
Busulfan—Hypertension—Capecitabine—esophageal cancer	0.000137	0.00129	CcSEcCtD
Busulfan—Haemoglobin—Methotrexate—esophageal cancer	0.000136	0.00128	CcSEcCtD
Busulfan—Haemorrhage—Methotrexate—esophageal cancer	0.000136	0.00127	CcSEcCtD
Busulfan—Chest pain—Capecitabine—esophageal cancer	0.000135	0.00127	CcSEcCtD
Busulfan—Myalgia—Capecitabine—esophageal cancer	0.000135	0.00127	CcSEcCtD
Busulfan—Arthralgia—Capecitabine—esophageal cancer	0.000135	0.00127	CcSEcCtD
Busulfan—Pharyngitis—Methotrexate—esophageal cancer	0.000135	0.00126	CcSEcCtD
Busulfan—GSTA1—Metabolism—CA2—esophageal cancer	0.000135	0.00112	CbGpPWpGaD
Busulfan—Anxiety—Capecitabine—esophageal cancer	0.000135	0.00126	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000134	0.00126	CcSEcCtD
Busulfan—Urinary tract disorder—Methotrexate—esophageal cancer	0.000134	0.00126	CcSEcCtD
Busulfan—Urethral disorder—Methotrexate—esophageal cancer	0.000133	0.00125	CcSEcCtD
Busulfan—Dry mouth—Capecitabine—esophageal cancer	0.000132	0.00124	CcSEcCtD
Busulfan—Confusional state—Capecitabine—esophageal cancer	0.000131	0.00123	CcSEcCtD
Busulfan—GSTM1—C-MYB transcription factor network—MYC—esophageal cancer	0.000131	0.00109	CbGpPWpGaD
Busulfan—Oedema—Capecitabine—esophageal cancer	0.00013	0.00122	CcSEcCtD
Busulfan—Hypersensitivity—Cisplatin—esophageal cancer	0.00013	0.00122	CcSEcCtD
Busulfan—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.00013	0.00108	CbGpPWpGaD
Busulfan—MGST2—Metabolism—ADH1B—esophageal cancer	0.000129	0.00107	CbGpPWpGaD
Busulfan—Infection—Capecitabine—esophageal cancer	0.000129	0.00121	CcSEcCtD
Busulfan—Erythema multiforme—Methotrexate—esophageal cancer	0.000128	0.0012	CcSEcCtD
Busulfan—Nervous system disorder—Capecitabine—esophageal cancer	0.000127	0.00119	CcSEcCtD
Busulfan—Eye disorder—Methotrexate—esophageal cancer	0.000127	0.00119	CcSEcCtD
Busulfan—Thrombocytopenia—Capecitabine—esophageal cancer	0.000127	0.00119	CcSEcCtD
Busulfan—Tachycardia—Capecitabine—esophageal cancer	0.000126	0.00119	CcSEcCtD
Busulfan—Asthenia—Cisplatin—esophageal cancer	0.000126	0.00118	CcSEcCtD
Busulfan—Cardiac disorder—Methotrexate—esophageal cancer	0.000126	0.00118	CcSEcCtD
Busulfan—Skin disorder—Capecitabine—esophageal cancer	0.000126	0.00118	CcSEcCtD
Busulfan—GSTA1—Metabolism—ADH7—esophageal cancer	0.000125	0.00104	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PLCE1—esophageal cancer	0.000125	0.00104	CbGpPWpGaD
Busulfan—Anorexia—Capecitabine—esophageal cancer	0.000124	0.00116	CcSEcCtD
Busulfan—MGST2—Metabolism—TYMP—esophageal cancer	0.000123	0.00103	CbGpPWpGaD
Busulfan—Angiopathy—Methotrexate—esophageal cancer	0.000123	0.00116	CcSEcCtD
Busulfan—Immune system disorder—Methotrexate—esophageal cancer	0.000123	0.00115	CcSEcCtD
Busulfan—Mediastinal disorder—Methotrexate—esophageal cancer	0.000122	0.00115	CcSEcCtD
Busulfan—Chills—Methotrexate—esophageal cancer	0.000122	0.00114	CcSEcCtD
Busulfan—Hypotension—Capecitabine—esophageal cancer	0.000121	0.00114	CcSEcCtD
Busulfan—Diarrhoea—Cisplatin—esophageal cancer	0.00012	0.00113	CcSEcCtD
Busulfan—MGST2—Metabolism—CYP26A1—esophageal cancer	0.00012	0.000999	CbGpPWpGaD
Busulfan—Alopecia—Methotrexate—esophageal cancer	0.00012	0.00113	CcSEcCtD
Busulfan—Mental disorder—Methotrexate—esophageal cancer	0.000119	0.00112	CcSEcCtD
Busulfan—Erythema—Methotrexate—esophageal cancer	0.000118	0.00111	CcSEcCtD
Busulfan—Malnutrition—Methotrexate—esophageal cancer	0.000118	0.00111	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000118	0.00111	CcSEcCtD
Busulfan—Insomnia—Capecitabine—esophageal cancer	0.000117	0.0011	CcSEcCtD
Busulfan—GSTA2—Metabolism—BLVRB—esophageal cancer	0.000117	0.000973	CbGpPWpGaD
Busulfan—MGST2—Metabolism—ALOX15—esophageal cancer	0.000117	0.000973	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—SLC52A3—esophageal cancer	0.000117	0.000973	CbGpPWpGaD
Busulfan—Dyspnoea—Capecitabine—esophageal cancer	0.000116	0.00108	CcSEcCtD
Busulfan—Back pain—Methotrexate—esophageal cancer	0.000114	0.00107	CcSEcCtD
Busulfan—Dyspepsia—Capecitabine—esophageal cancer	0.000114	0.00107	CcSEcCtD
Busulfan—GSTM1—Metabolism—BLVRB—esophageal cancer	0.000114	0.000947	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—SLC52A3—esophageal cancer	0.000114	0.000947	CbGpPWpGaD
Busulfan—Decreased appetite—Capecitabine—esophageal cancer	0.000113	0.00106	CcSEcCtD
Busulfan—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000112	0.00105	CcSEcCtD
Busulfan—Vomiting—Cisplatin—esophageal cancer	0.000112	0.00105	CcSEcCtD
Busulfan—Fatigue—Capecitabine—esophageal cancer	0.000112	0.00105	CcSEcCtD
Busulfan—MGST2—Metabolism—TPI1—esophageal cancer	0.000112	0.000928	CbGpPWpGaD
Busulfan—MGST2—Metabolism—GSTO1—esophageal cancer	0.000112	0.000928	CbGpPWpGaD
Busulfan—Rash—Cisplatin—esophageal cancer	0.000111	0.00104	CcSEcCtD
Busulfan—Pain—Capecitabine—esophageal cancer	0.000111	0.00104	CcSEcCtD
Busulfan—Constipation—Capecitabine—esophageal cancer	0.000111	0.00104	CcSEcCtD
Busulfan—Dermatitis—Cisplatin—esophageal cancer	0.000111	0.00104	CcSEcCtD
Busulfan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00011	0.000914	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—ADH1B—esophageal cancer	0.00011	0.000913	CbGpPWpGaD
Busulfan—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.000109	0.000909	CbGpPWpGaD
Busulfan—Anaemia—Methotrexate—esophageal cancer	0.000109	0.00103	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—SOD2—esophageal cancer	0.000109	0.000908	CbGpPWpGaD
Busulfan—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.000108	0.000902	CbGpPWpGaD
Busulfan—MGST2—Metabolism—ALDOB—esophageal cancer	0.000107	0.00089	CbGpPWpGaD
Busulfan—Feeling abnormal—Capecitabine—esophageal cancer	0.000107	0.001	CcSEcCtD
Busulfan—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000106	0.000994	CcSEcCtD
Busulfan—Leukopenia—Methotrexate—esophageal cancer	0.000106	0.000993	CcSEcCtD
Busulfan—GSTA1—Metabolism—TYMP—esophageal cancer	0.000105	0.000873	CbGpPWpGaD
Busulfan—Nausea—Cisplatin—esophageal cancer	0.000104	0.00098	CcSEcCtD
Busulfan—Cough—Methotrexate—esophageal cancer	0.000103	0.000968	CcSEcCtD
Busulfan—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.000103	0.000857	CbGpPWpGaD
Busulfan—MGST2—Metabolism—GAPDH—esophageal cancer	0.000103	0.000857	CbGpPWpGaD
Busulfan—Urticaria—Capecitabine—esophageal cancer	0.000103	0.000966	CcSEcCtD
Busulfan—Abdominal pain—Capecitabine—esophageal cancer	0.000102	0.000961	CcSEcCtD
Busulfan—Body temperature increased—Capecitabine—esophageal cancer	0.000102	0.000961	CcSEcCtD
Busulfan—Convulsion—Methotrexate—esophageal cancer	0.000102	0.000961	CcSEcCtD
Busulfan—GSTA1—Metabolism—CYP26A1—esophageal cancer	0.000102	0.000849	CbGpPWpGaD
Busulfan—MGST2—Metabolism—CRABP1—esophageal cancer	0.000102	0.000849	CbGpPWpGaD
Busulfan—Myalgia—Methotrexate—esophageal cancer	0.000101	0.000944	CcSEcCtD
Busulfan—Chest pain—Methotrexate—esophageal cancer	0.000101	0.000944	CcSEcCtD
Busulfan—Arthralgia—Methotrexate—esophageal cancer	0.000101	0.000944	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.0001	0.000938	CcSEcCtD
Busulfan—GSTA1—Metabolism—ALOX15—esophageal cancer	9.95e-05	0.000827	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—SLC10A2—esophageal cancer	9.95e-05	0.000827	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CA1—esophageal cancer	9.95e-05	0.000827	CbGpPWpGaD
Busulfan—Confusional state—Methotrexate—esophageal cancer	9.73e-05	0.000913	CcSEcCtD
Busulfan—MGST2—Metabolism—GNG7—esophageal cancer	9.71e-05	0.000808	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—SLC52A3—esophageal cancer	9.68e-05	0.000805	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—SLC10A2—esophageal cancer	9.68e-05	0.000805	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CA1—esophageal cancer	9.68e-05	0.000805	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—BLVRB—esophageal cancer	9.68e-05	0.000805	CbGpPWpGaD
Busulfan—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	9.59e-05	0.000797	CbGpPWpGaD
Busulfan—Infection—Methotrexate—esophageal cancer	9.59e-05	0.000899	CcSEcCtD
Busulfan—Hypersensitivity—Capecitabine—esophageal cancer	9.55e-05	0.000896	CcSEcCtD
Busulfan—GSTA1—Metabolism—GSTO1—esophageal cancer	9.49e-05	0.000789	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—TPI1—esophageal cancer	9.49e-05	0.000789	CbGpPWpGaD
Busulfan—Nervous system disorder—Methotrexate—esophageal cancer	9.46e-05	0.000888	CcSEcCtD
Busulfan—Thrombocytopenia—Methotrexate—esophageal cancer	9.45e-05	0.000886	CcSEcCtD
Busulfan—Skin disorder—Methotrexate—esophageal cancer	9.37e-05	0.000879	CcSEcCtD
Busulfan—Asthenia—Capecitabine—esophageal cancer	9.3e-05	0.000873	CcSEcCtD
Busulfan—Anorexia—Methotrexate—esophageal cancer	9.2e-05	0.000863	CcSEcCtD
Busulfan—Pruritus—Capecitabine—esophageal cancer	9.17e-05	0.00086	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—HIF1A—esophageal cancer	9.16e-05	0.000762	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CA2—esophageal cancer	9.1e-05	0.000757	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—ALDOB—esophageal cancer	9.1e-05	0.000757	CbGpPWpGaD
Busulfan—MGST2—Metabolism—ALDH2—esophageal cancer	9.1e-05	0.000757	CbGpPWpGaD
Busulfan—Hypotension—Methotrexate—esophageal cancer	9.02e-05	0.000846	CcSEcCtD
Busulfan—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	8.91e-05	0.000741	CbGpPWpGaD
Busulfan—Diarrhoea—Capecitabine—esophageal cancer	8.87e-05	0.000832	CcSEcCtD
Busulfan—GSTM1—Metabolism—CA2—esophageal cancer	8.85e-05	0.000736	CbGpPWpGaD
Busulfan—Musculoskeletal discomfort—Methotrexate—esophageal cancer	8.79e-05	0.000825	CcSEcCtD
Busulfan—GSTA1—Metabolism—GAPDH—esophageal cancer	8.76e-05	0.000729	CbGpPWpGaD
Busulfan—Insomnia—Methotrexate—esophageal cancer	8.73e-05	0.000819	CcSEcCtD
Busulfan—GSTA1—Metabolism—CRABP1—esophageal cancer	8.68e-05	0.000722	CbGpPWpGaD
Busulfan—MGST2—Metabolism—GSTT1—esophageal cancer	8.66e-05	0.00072	CbGpPWpGaD
Busulfan—Dyspnoea—Methotrexate—esophageal cancer	8.6e-05	0.000807	CcSEcCtD
Busulfan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	8.6e-05	0.000715	CbGpPWpGaD
Busulfan—Somnolence—Methotrexate—esophageal cancer	8.58e-05	0.000805	CcSEcCtD
Busulfan—Dizziness—Capecitabine—esophageal cancer	8.57e-05	0.000804	CcSEcCtD
Busulfan—MGST2—Metabolism—CYP2A6—esophageal cancer	8.56e-05	0.000712	CbGpPWpGaD
Busulfan—Dyspepsia—Methotrexate—esophageal cancer	8.49e-05	0.000797	CcSEcCtD
Busulfan—GSTA2—Metabolism—PLCE1—esophageal cancer	8.46e-05	0.000704	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—ADH7—esophageal cancer	8.46e-05	0.000704	CbGpPWpGaD
Busulfan—Decreased appetite—Methotrexate—esophageal cancer	8.39e-05	0.000787	CcSEcCtD
Busulfan—Gastrointestinal disorder—Methotrexate—esophageal cancer	8.33e-05	0.000782	CcSEcCtD
Busulfan—Fatigue—Methotrexate—esophageal cancer	8.32e-05	0.000781	CcSEcCtD
Busulfan—GSTA1—Metabolism—GNG7—esophageal cancer	8.26e-05	0.000687	CbGpPWpGaD
Busulfan—Pain—Methotrexate—esophageal cancer	8.25e-05	0.000774	CcSEcCtD
Busulfan—Vomiting—Capecitabine—esophageal cancer	8.24e-05	0.000773	CcSEcCtD
Busulfan—GSTP1—Metabolism—CA1—esophageal cancer	8.23e-05	0.000684	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—ADH7—esophageal cancer	8.23e-05	0.000684	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—SLC10A2—esophageal cancer	8.23e-05	0.000684	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PLCE1—esophageal cancer	8.23e-05	0.000684	CbGpPWpGaD
Busulfan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	8.19e-05	0.000681	CbGpPWpGaD
Busulfan—Rash—Capecitabine—esophageal cancer	8.17e-05	0.000767	CcSEcCtD
Busulfan—Dermatitis—Capecitabine—esophageal cancer	8.16e-05	0.000766	CcSEcCtD
Busulfan—Headache—Capecitabine—esophageal cancer	8.12e-05	0.000762	CcSEcCtD
Busulfan—MGST2—Metabolism—PTGS1—esophageal cancer	8.11e-05	0.000675	CbGpPWpGaD
Busulfan—MGST2—Metabolism—ENO1—esophageal cancer	8.11e-05	0.000675	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PSME2—esophageal cancer	7.99e-05	0.000665	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PSME1—esophageal cancer	7.99e-05	0.000665	CbGpPWpGaD
Busulfan—Feeling abnormal—Methotrexate—esophageal cancer	7.95e-05	0.000746	CcSEcCtD
Busulfan—Gastrointestinal pain—Methotrexate—esophageal cancer	7.89e-05	0.00074	CcSEcCtD
Busulfan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	7.83e-05	0.000651	CbGpPWpGaD
Busulfan—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	7.81e-05	0.000649	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—ALDH2—esophageal cancer	7.74e-05	0.000644	CbGpPWpGaD
Busulfan—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	7.73e-05	0.000643	CbGpPWpGaD
Busulfan—Nausea—Capecitabine—esophageal cancer	7.7e-05	0.000722	CcSEcCtD
Busulfan—Urticaria—Methotrexate—esophageal cancer	7.66e-05	0.000719	CcSEcCtD
Busulfan—Body temperature increased—Methotrexate—esophageal cancer	7.63e-05	0.000716	CcSEcCtD
Busulfan—Abdominal pain—Methotrexate—esophageal cancer	7.63e-05	0.000716	CcSEcCtD
Busulfan—GSTP1—Metabolism—CA2—esophageal cancer	7.53e-05	0.000626	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—CREBBP—esophageal cancer	7.49e-05	0.000622	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—RB1—esophageal cancer	7.46e-05	0.00062	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—ADH1B—esophageal cancer	7.42e-05	0.000617	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—GSTT1—esophageal cancer	7.36e-05	0.000612	CbGpPWpGaD
Busulfan—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	7.34e-05	0.000611	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—CYP2A6—esophageal cancer	7.28e-05	0.000605	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—ADH1B—esophageal cancer	7.22e-05	0.0006	CbGpPWpGaD
Busulfan—Hypersensitivity—Methotrexate—esophageal cancer	7.11e-05	0.000667	CcSEcCtD
Busulfan—GSTA2—Metabolism—TYMP—esophageal cancer	7.09e-05	0.00059	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PLCE1—esophageal cancer	7e-05	0.000582	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—ADH7—esophageal cancer	7e-05	0.000582	CbGpPWpGaD
Busulfan—Asthenia—Methotrexate—esophageal cancer	6.92e-05	0.00065	CcSEcCtD
Busulfan—GSTA2—Metabolism—CYP26A1—esophageal cancer	6.9e-05	0.000574	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PTGS1—esophageal cancer	6.9e-05	0.000574	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—ENO1—esophageal cancer	6.9e-05	0.000574	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—TYMP—esophageal cancer	6.9e-05	0.000574	CbGpPWpGaD
Busulfan—MGST2—Metabolism—CYP1B1—esophageal cancer	6.9e-05	0.000574	CbGpPWpGaD
Busulfan—Pruritus—Methotrexate—esophageal cancer	6.83e-05	0.000641	CcSEcCtD
Busulfan—GSTA1—Metabolism—PSME1—esophageal cancer	6.8e-05	0.000565	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PSME2—esophageal cancer	6.8e-05	0.000565	CbGpPWpGaD
Busulfan—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	6.75e-05	0.000562	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—ALOX15—esophageal cancer	6.72e-05	0.000559	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CYP26A1—esophageal cancer	6.71e-05	0.000558	CbGpPWpGaD
Busulfan—Diarrhoea—Methotrexate—esophageal cancer	6.6e-05	0.000619	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—CDKN2A—esophageal cancer	6.56e-05	0.000545	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—ALOX15—esophageal cancer	6.54e-05	0.000544	CbGpPWpGaD
Busulfan—MGST2—Metabolism—CYP19A1—esophageal cancer	6.49e-05	0.000539	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—GSTO1—esophageal cancer	6.41e-05	0.000533	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—TPI1—esophageal cancer	6.41e-05	0.000533	CbGpPWpGaD
Busulfan—Dizziness—Methotrexate—esophageal cancer	6.38e-05	0.000599	CcSEcCtD
Busulfan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	6.35e-05	0.000528	CbGpPWpGaD
Busulfan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	6.31e-05	0.000525	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—GSTO1—esophageal cancer	6.24e-05	0.000519	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—TPI1—esophageal cancer	6.24e-05	0.000519	CbGpPWpGaD
Busulfan—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	6.23e-05	0.000518	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—ALDOB—esophageal cancer	6.15e-05	0.000511	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—ADH1B—esophageal cancer	6.14e-05	0.00051	CbGpPWpGaD
Busulfan—Vomiting—Methotrexate—esophageal cancer	6.13e-05	0.000576	CcSEcCtD
Busulfan—Rash—Methotrexate—esophageal cancer	6.08e-05	0.000571	CcSEcCtD
Busulfan—Dermatitis—Methotrexate—esophageal cancer	6.08e-05	0.00057	CcSEcCtD
Busulfan—Headache—Methotrexate—esophageal cancer	6.04e-05	0.000567	CcSEcCtD
Busulfan—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	6.02e-05	0.000501	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—ALDOB—esophageal cancer	5.98e-05	0.000497	CbGpPWpGaD
Busulfan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	5.94e-05	0.000494	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—GAPDH—esophageal cancer	5.92e-05	0.000492	CbGpPWpGaD
Busulfan—MGST2—Metabolism—HMOX1—esophageal cancer	5.92e-05	0.000492	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CRABP1—esophageal cancer	5.86e-05	0.000488	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—CYP1B1—esophageal cancer	5.86e-05	0.000488	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—TYMP—esophageal cancer	5.86e-05	0.000488	CbGpPWpGaD
Busulfan—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	5.86e-05	0.000487	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—ADH7—esophageal cancer	5.81e-05	0.000483	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—GAPDH—esophageal cancer	5.76e-05	0.000479	CbGpPWpGaD
Busulfan—Nausea—Methotrexate—esophageal cancer	5.73e-05	0.000538	CcSEcCtD
Busulfan—GSTM1—Metabolism—CRABP1—esophageal cancer	5.71e-05	0.000474	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CYP26A1—esophageal cancer	5.71e-05	0.000474	CbGpPWpGaD
Busulfan—MGST2—Metabolism—ABCB1—esophageal cancer	5.68e-05	0.000472	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—GNG7—esophageal cancer	5.58e-05	0.000464	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—ALOX15—esophageal cancer	5.56e-05	0.000462	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—CYP19A1—esophageal cancer	5.51e-05	0.000459	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—GNG7—esophageal cancer	5.43e-05	0.000451	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—CDKN1A—esophageal cancer	5.36e-05	0.000446	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—TPI1—esophageal cancer	5.3e-05	0.000441	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GSTO1—esophageal cancer	5.3e-05	0.000441	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—ALDH2—esophageal cancer	5.23e-05	0.000435	CbGpPWpGaD
Busulfan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	5.12e-05	0.000426	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—EP300—esophageal cancer	5.1e-05	0.000424	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	5.09e-05	0.000423	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—ALDOB—esophageal cancer	5.09e-05	0.000423	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—ALDH2—esophageal cancer	5.09e-05	0.000423	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—HMOX1—esophageal cancer	5.03e-05	0.000418	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—GSTT1—esophageal cancer	4.97e-05	0.000413	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CYP2A6—esophageal cancer	4.91e-05	0.000409	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GAPDH—esophageal cancer	4.89e-05	0.000407	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CRABP1—esophageal cancer	4.85e-05	0.000403	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—GSTT1—esophageal cancer	4.84e-05	0.000402	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—ABCB1—esophageal cancer	4.83e-05	0.000402	CbGpPWpGaD
Busulfan—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	4.81e-05	0.0004	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CYP2A6—esophageal cancer	4.78e-05	0.000398	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	4.73e-05	0.000394	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	4.67e-05	0.000388	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—ENO1—esophageal cancer	4.66e-05	0.000387	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PTGS1—esophageal cancer	4.66e-05	0.000387	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GNG7—esophageal cancer	4.61e-05	0.000384	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PSME2—esophageal cancer	4.59e-05	0.000382	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PSME1—esophageal cancer	4.59e-05	0.000382	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—ENO1—esophageal cancer	4.53e-05	0.000377	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PTGS1—esophageal cancer	4.53e-05	0.000377	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PSME2—esophageal cancer	4.47e-05	0.000371	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PSME1—esophageal cancer	4.47e-05	0.000371	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	4.4e-05	0.000366	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	4.34e-05	0.000361	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—ALDH2—esophageal cancer	4.32e-05	0.00036	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GSTT1—esophageal cancer	4.11e-05	0.000342	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CYP2A6—esophageal cancer	4.07e-05	0.000338	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CYP1B1—esophageal cancer	3.96e-05	0.000329	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CYP1B1—esophageal cancer	3.85e-05	0.00032	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—ENO1—esophageal cancer	3.85e-05	0.00032	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PTGS1—esophageal cancer	3.85e-05	0.00032	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PSME2—esophageal cancer	3.8e-05	0.000316	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PSME1—esophageal cancer	3.8e-05	0.000316	CbGpPWpGaD
Busulfan—MGST2—Metabolism—CREBBP—esophageal cancer	3.8e-05	0.000316	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CYP19A1—esophageal cancer	3.72e-05	0.00031	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—TP53—esophageal cancer	3.65e-05	0.000303	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CYP19A1—esophageal cancer	3.62e-05	0.000301	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	3.59e-05	0.000298	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	3.41e-05	0.000284	CbGpPWpGaD
Busulfan—MGST2—Metabolism—NOS3—esophageal cancer	3.4e-05	0.000283	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—HMOX1—esophageal cancer	3.4e-05	0.000283	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	3.37e-05	0.00028	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—HMOX1—esophageal cancer	3.31e-05	0.000275	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CYP1B1—esophageal cancer	3.28e-05	0.000272	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—ABCB1—esophageal cancer	3.26e-05	0.000271	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—CREBBP—esophageal cancer	3.23e-05	0.000268	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	3.2e-05	0.000266	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—ABCB1—esophageal cancer	3.17e-05	0.000264	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PTGS2—esophageal cancer	3.11e-05	0.000259	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CYP19A1—esophageal cancer	3.08e-05	0.000256	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—NOS3—esophageal cancer	2.89e-05	0.00024	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—HMOX1—esophageal cancer	2.81e-05	0.000234	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	2.72e-05	0.000226	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—ABCB1—esophageal cancer	2.7e-05	0.000224	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	2.68e-05	0.000223	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PTGS2—esophageal cancer	2.64e-05	0.00022	CbGpPWpGaD
Busulfan—MGST2—Metabolism—EP300—esophageal cancer	2.59e-05	0.000215	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	2.56e-05	0.000213	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	2.52e-05	0.00021	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—EP300—esophageal cancer	2.2e-05	0.000183	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CREBBP—esophageal cancer	2.18e-05	0.000181	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CREBBP—esophageal cancer	2.12e-05	0.000176	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—NOS3—esophageal cancer	1.95e-05	0.000162	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PIK3CA—esophageal cancer	1.91e-05	0.000159	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—NOS3—esophageal cancer	1.9e-05	0.000158	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CREBBP—esophageal cancer	1.8e-05	0.00015	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PTGS2—esophageal cancer	1.79e-05	0.000148	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PTGS2—esophageal cancer	1.74e-05	0.000144	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PIK3CA—esophageal cancer	1.63e-05	0.000135	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—NOS3—esophageal cancer	1.61e-05	0.000134	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—EP300—esophageal cancer	1.48e-05	0.000123	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PTGS2—esophageal cancer	1.48e-05	0.000123	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—EP300—esophageal cancer	1.44e-05	0.00012	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.37e-05	0.000114	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.37e-05	0.000114	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—EP300—esophageal cancer	1.23e-05	0.000102	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CA1—esophageal cancer	1.17e-05	9.71e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.17e-05	9.71e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PIK3CA—esophageal cancer	1.1e-05	9.13e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PIK3CA—esophageal cancer	1.07e-05	8.89e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CA2—esophageal cancer	1.07e-05	8.88e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ADH7—esophageal cancer	9.93e-06	8.26e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PLCE1—esophageal cancer	9.93e-06	8.26e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PIK3CA—esophageal cancer	9.09e-06	7.56e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ADH1B—esophageal cancer	8.71e-06	7.24e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—TYMP—esophageal cancer	8.32e-06	6.92e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CYP26A1—esophageal cancer	8.1e-06	6.73e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ALOX15—esophageal cancer	7.89e-06	6.56e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTO1—esophageal cancer	7.53e-06	6.26e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—TPI1—esophageal cancer	7.53e-06	6.26e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ALDOB—esophageal cancer	7.22e-06	6e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.95e-06	5.78e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.88e-06	5.72e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GNG7—esophageal cancer	6.55e-06	5.44e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ALDH2—esophageal cancer	6.13e-06	5.1e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.84e-06	4.85e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.77e-06	4.8e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ENO1—esophageal cancer	5.47e-06	4.55e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PTGS1—esophageal cancer	5.47e-06	4.55e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PSME1—esophageal cancer	5.39e-06	4.48e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PSME2—esophageal cancer	5.39e-06	4.48e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.65e-06	3.87e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CYP19A1—esophageal cancer	4.37e-06	3.64e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.99e-06	3.32e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.83e-06	3.18e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.56e-06	2.13e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NOS3—esophageal cancer	2.29e-06	1.91e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.1e-06	1.74e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—EP300—esophageal cancer	1.74e-06	1.45e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.29e-06	1.07e-05	CbGpPWpGaD
